Covid-19: Molnupiravir tablet can be game-changer in stopping coronavirus transmission
4 years ago

Covid-19: Molnupiravir tablet can be game-changer in stopping coronavirus transmission

India Today  

A new drug has become the talk of the town to fight Covid-19. If the experiment carried out in an American university holds true in larger human trials, this could be the magical cure that the world has been waiting for in its fight against Covid-19. The scientists at the Institute of Biomedical Sciences in the American state of Georgia have found that Molnupiravir stops the transmission of SARS-CoV-2, the coronavirus that causes Covid-19, from one ferret to another within 24 hours. The Molnupiravir experiment is the first demonstration of an orally available drug that is effective against SARS-CoV-2 coronavirus. When the animals started shedding coronavirus from their nostrils, the scientists gave one group of ferrets Molnupiravir drug, and the other placebo.

Coronavirus Covid Drug Human Trials Molnupiravir Remdesivir  stopping  tablet  coronavirus  molnupiravir  human  experiment  trials  gamechanger  drug  ferrets  transmission  treatment  covid19  scientists

History of this topic

Molnupiravir Leads To Quicker Recovery In Vaccinated Adults Infected With Covid Does Not Reduce Hospital Admission Or Death Study In Lancet
2 years ago

Molnupiravir Leads To Quicker Recovery In Vaccinated Adults Infected With Covid Does Not Reduce Hospital Admission Or Death Study In Lancet

ABP News  

Molnupiravir leads to quicker recovery in vaccinated adults infected with Covid-19, compared to individuals who did not consume the pills, according to a new study published in The Lancet journal. The study also found that molnupiravir does not reduce hospitalisation or death in vaccinated adults infected with Covid-19, who are at a higher risk of mortality. Quicker recovery in patients …

New intranasal anti-viral treatment may block Covid transmission
2 years, 3 months ago

New intranasal anti-viral treatment may block Covid transmission

India TV News  

Covid news : Researchers have developed an intranasal anti-viral treatment for COVID-19 that decreases the amount of SARS-CoV-2 shed from infected animals and limits transmission of the virus. In a new study published in the journal Proceedings of the National Academy of Sciences, they show that this treatment, called a therapeutic interfering particle, also decreases the amount of virus shed …

Health Matters: Dear Drug Regulator, Silence is Not Always Golden, Esp on WHO Pausing Covaxin Supply
2 years, 8 months ago

Health Matters: Dear Drug Regulator, Silence is Not Always Golden, Esp on WHO Pausing Covaxin Supply

News 18  

On April 2, the World Health Organization suspended the supply of Bharat Biotech’s Covaxin through the UN agencies after finding issues with the “good manufacturing practices”. For the past 15 days, not only health journalists, but even commoners who got Covaxin jabs are hoping to hear from the country’s drug regulatory agency – Central Drugs Standard Control Organization. Eventually, the …

COVID-19 pills could be a game-changer, but doctors trying to use them face hurdles
2 years, 9 months ago

COVID-19 pills could be a game-changer, but doctors trying to use them face hurdles

LA Times  

Jeff Carlson, a Type 1 diabetic with heart stents, came down with COVID-19 in January, but recovered quickly after being treated with Merck’s molnupiravir. With vaccines and treatments available, “we can make this much more manageable in the future, if people are willing to take care of themselves,” said Dr. Bryan Jarabek, who helps lead COVID-19 treatment and vaccination efforts …

Covid pill could also treat future variants and other viruses, scientists claim
2 years, 11 months ago

Covid pill could also treat future variants and other viruses, scientists claim

The Telegraph  

The antiviral pill that reduces the risk of dying from Covid by 30 per cent will work against future variants and may also be able to treat flu, according to the drug’s creators. “Looking ahead to the future, we have laboratory data that suggests molnupiravir is effective against a multitude of RNA viruses, including influenza, and we are looking at …

No molnupiravir: ICMR team
2 years, 11 months ago

No molnupiravir: ICMR team

The Hindu  

The ICMR’s National Task Force for COVID-19 has decided against including antiviral drug molnupiravir in the Clinical Management Protocol for COVID-19 as of now, official sources said on Tuesday. The experts of the task force cited safety concerns, and argued that Molnupiravir was not of much benefit in COVID treatment to arrive at the decision in a meeting held on …

Lupin launches antiviral medication Molnulup for COVID-19 treatment in India
2 years, 11 months ago

Lupin launches antiviral medication Molnulup for COVID-19 treatment in India

Firstpost  

Molnupiravir has been given emergency use authorisation by the DCGI for treatment of adult COVID-19 patients who have a high risk of progression of the disease, including hospitalisation. New Delhi: Drugmaker Lupin on Friday said it has launched antiviral medication Molnupiravir under the brand name Molnulup in the country for the treatment of COVID-19. Molnupiravir has been given emergency use …

Covid antiviral drug Molnupiravir has major safety concerns: ICMR chief
2 years, 11 months ago

Covid antiviral drug Molnupiravir has major safety concerns: ICMR chief

The Hindu  

ICMR Chief Dr. Balram Bhargava said on January 5 that Covid antiviral drug Molnupiravir has major safety concerns and has not been included in the national protocol for treatment of coronavirus. “Molnupiravir will now be manufactured in the country by 13 companies for restricted use under emergency situations for treatment of adult patients with COVID-19 and who have high risk …

Molnupiravir, oral anti-Covid medicine, set for launch in India; to cost Rs 649 per strip
2 years, 11 months ago

Molnupiravir, oral anti-Covid medicine, set for launch in India; to cost Rs 649 per strip

India TV News  

Molnupiravir, the world’s first and only oral antiviral to be approved by the US FDA, UK MHRA and Indian CDSCO for treatment of COVID-19, is set for a launch. Last week, the Drugs Controller General of India, based on the review of clinical data of molnupiravir, approved molnupiravir for treatment of adult patients with Covid-19, with SpO2 > 93% and …

Optimus Pharma to launch anti-COVID pill Molnupiravir next week; all you need to know
2 years, 11 months ago

Optimus Pharma to launch anti-COVID pill Molnupiravir next week; all you need to know

Firstpost  

Molnupiravir, developed by US-based biotechnology company Ridgeback Biotherapeutics in collaboration with US pharma giant Merck, was approved for emergency use in India on Tuesday The Drug Controller General of India had earlier this week approved Molnupiravir for restricted use in an emergency situation in India. Brinton Pharmaceuticals on Thursday said it will launch its generic version of anti-COVID-19 pill Molnupiravir …

Approved by India, Full Treatment of Anti-Viral Drug Molnupiravir May Cost Up to Rs 3,000: Report
2 years, 11 months ago

Approved by India, Full Treatment of Anti-Viral Drug Molnupiravir May Cost Up to Rs 3,000: Report

News 18  

Anti-viral drug Molnupiravir, which has got the green flag from the Drug Controller General of India for emergency use approval to treat Covid-19, is expected to cost between ₹2,000 and ₹3,000 for full treatment. Earlier, Merck had said it “plans to implement a tiered pricing approach based on World Bank country income criteria to reflect countries’ relative ability to finance …

Paxlovid and Molnupiravir | A new front in the battle against the pandemic
2 years, 11 months ago

Paxlovid and Molnupiravir | A new front in the battle against the pandemic

The Hindu  

The U.S. Food and Drugs Administration has given an Emergency Use Authorisation to two drugs: Paxlovid, a treatment regimen developed by Pfizer Inc for treating mild-to-moderate Covid-19 in adults and children 12 years and older, who are likely to be at greater risk for severe infection, and Molnupiravir, developed by Merck and Ridgeback Biotherapeutics to treat mild-to-moderate COVID-19 in adults …

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment
3 years ago

A shot in the arm: The Hindu Editorial on new modes of COVID-19 treatment

The Hindu  

If full vaccination using any COVID-19 vaccine greatly reduces a person’s risk of progressing to severe disease and death, then the move by the U.S. FDA to grant emergency-use authorisation to two oral antiviral drugs for certain categories of people who are likely to become severely ill provides a much-needed fillip to fight the disease. Unlike in the case of …

Chandrakant Lahariya | FDA approval of Covid pill a sign of hope for the world
3 years ago

Chandrakant Lahariya | FDA approval of Covid pill a sign of hope for the world

Deccan Chronicle  

On December 22, the US Food and Drugs Administration approved an oral Covid-19 drug Paxlovid. This understanding has practical relevance in Covid-19 clinical management, that the antiviral drugs work better in the first phase and the immunomodulators, immunosuppressive/anti-inflammatory drugs in the later phase. Nearly all currently available Covid-19 drugs need to be given either intravenously or through injections, in hospital …

U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19
3 years ago

U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19

LA Times  

U.S. regulators have authorized a second pill against COVID-19: molnupiravir, an antiviral drug from Merck that may help blunt the wave of coronavirus infections. The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions such as obesity and heart disease. Additionally, …

Merck’s at-home antiviral COVID-19 pill approved by US regulator
3 years ago

Merck’s at-home antiviral COVID-19 pill approved by US regulator

Al Jazeera  

United States health regulators have authorised a second antiviral pill against COVID-19, providing another easy-to-use medication to battle the rising tide of Omicron infections. Additionally, Pfizer’s drug was roughly three times more effective in testing than Merck’s, reducing hospitalisation and death by nearly 90 percent among high-risk patients. Merck’s drug is not authorised for use in patients younger than 18 …

Merck's Covid-19 pill Molnupiravir found to reduce hospitalisation, death risks
3 years ago

Merck's Covid-19 pill Molnupiravir found to reduce hospitalisation, death risks

India Today  

As Covid-19 cases peak across the world including the US and the UK, Molnupiravir, an oral drug developed by Merck, could act as a counter. In the phase-III clinical trials, the drug was found to reduce the risk of hospitalisation and death in at-risk, unvaccinated adults, Molnupiravir is an oral, small-molecule antiviral prodrug that is active against severe acute respiratory …

UK planning to rollout Merck's anti-Covid pill as soon as Christmas: Report
3 years ago

UK planning to rollout Merck's anti-Covid pill as soon as Christmas: Report

Hindustan Times  

The government in the United Kingdom is planning to roll out the antiviral pill against Coronavirus disease as part of an offered treatment against the viral disease, according to a report by Sunday Telegraph. The pill -- Molnupiravir -- has been developed by American pharmaceutical company Merck and has been touted as "game-changing" as it can be taken from the …

Merck’s covid-19 pill backed by FDA advisers
3 years ago

Merck’s covid-19 pill backed by FDA advisers

Live Mint  

An outside panel of scientific advisers to the Food and Drug Administration narrowly recommended the agency authorize the experimental Covid-19 oral antiviral from Merck & Co. and partner Ridgeback Biotherapeutics LP. Several panel members who voted in favor of authorization said use of molnupiravir should be limited to unvaccinated people at high risk of Covid-19 complications, and that while more …

Merck’s covid-19 pill to be reviewed by FDA advisers
3 years ago

Merck’s covid-19 pill to be reviewed by FDA advisers

Live Mint  

An outside panel of scientific advisers to the Food and Drug Administration is scheduled to meet Tuesday to discuss the experimental Covid-19 oral antiviral from Merck & Co. and partner Ridgeback Biotherapeutics LP. Researchers plan to study molnupiravir and Omicron soon but think the drug could be effective because it has been found to work against other Covid-19 variants, the …

New antiviral drugs are coming for COVID. Here's what you need to know
3 years ago

New antiviral drugs are coming for COVID. Here's what you need to know

NPR  

New antiviral drugs are coming for COVID. Given the higher efficacy of the antibody treatments, "I think we will continue to use those, particularly for high risk people," says Dr. Rajesh Gandhi, an infectious diseases physician at Massachusetts General Hospital and Harvard Medical School who serves on COVID-19 Treatment Guidelines Panels for the NIH and the Infectious Diseases Society of …

Merck’s COVID pill shows lower efficacy in updated study
3 years ago

Merck’s COVID pill shows lower efficacy in updated study

Al Jazeera  

Drugmaker says final analysis of trial results showed molnupiravir led to 30 percent reduction in hospitalisations and deaths, compared with about 50 percent in interim study. Drugmaker Merck’s experimental COVID-19 pill is significantly less effective in slashing hospitalisations and deaths than previously reported, the company has said, following the release of a full analysis of trial results. The United States-based …

Merck asks EU drug regulator to authorise its Covid-19 pill
3 years, 1 month ago

Merck asks EU drug regulator to authorise its Covid-19 pill

Hindustan Times  

The European Medicines Agency said it has received a request from Merck to authorise its coronavirus antiviral, the first pill shown to treat Covid-19. In a statement Tuesday, the EU drug regulator said it had started evaluating molnupiravir, made by Merck and Ridgeback Biotherapeutics, and that a decision could be made within weeks on whether it might be cleared. Last …

Finally, pills to treat Covid-19! All you need to know about Pfizer's Paxlovid and Merck's Molnupiravir
3 years, 1 month ago

Finally, pills to treat Covid-19! All you need to know about Pfizer's Paxlovid and Merck's Molnupiravir

India Today  

Vaccines have been the primary antidote in the battle against Covid-19 to date, but we could have at least two game-changers in the form of American pharmaceutical giant Pfizer's antiviral pill Paxlovid, and Molnupiravir, manufactured by Merck, Sharp and Dohme, and Ridgeback Biotherapeutics. The preliminary data of Pfizer's experimental antiviral pill to treat Covid-19 shows an 89 per cent decrease …

UK approves Merck's antiviral COVID pill molnupiravir in world first
3 years, 1 month ago

UK approves Merck's antiviral COVID pill molnupiravir in world first

ABC  

Britain has become the first country in the world to approve Merck's potentially game-changing COVID-19 antiviral pill. Key points: US advisers will meet this month to vote on whether molnupiravir should be authorised Australia has already ordered 300,000 courses Merck is expecting to produce 10 million courses by the end of this year The UK's Medicines and Healthcare products Regulatory …

UK becomes first country to approve Merck's anti-Covid pill molnupiravir
3 years, 1 month ago

UK becomes first country to approve Merck's anti-Covid pill molnupiravir

Hindustan Times  

Britain on Thursday approved the use of Merck's antiviral pill to treat patients suffering from mild to moderate Covid-19, the Medicines and Healthcare products Regulatory Agency announced. Based on the clinical trial data, the drug is most effective when taken during the early stages of infection and the MHRA recommends that it be used within five days of the onset …

UK approves Merck’s antiviral COVID-19 pill in world first move
3 years, 1 month ago

UK approves Merck’s antiviral COVID-19 pill in world first move

Al Jazeera  

Merck’s molnupiravir to be given to recently-infected COVID-19 patients twice a day, for five days. The United Kingdom has become the first country in the world to approve a potentially game-changing COVID-19 antiviral pill jointly developed by Merck and Ridgeback Biotherapeutics. Merck’s molnupiravir has been closely watched since data last month showed it could halve the chances of dying or …

Molnupiravir: UK authorizes Merck/Ridgeback Biotherapeutics’ antiviral to treat mild-to-moderate Covid-19
3 years, 1 month ago

Molnupiravir: UK authorizes Merck/Ridgeback Biotherapeutics’ antiviral to treat mild-to-moderate Covid-19

CNN  

CNN — The UK Medicines and Healthcare Products Regulatory Agency said Thursday it had authorized Merck and Ridgeback Biotherapeutics’ oral antiviral, molnupiravir, to treat mild-to-moderate Covid-19 in adults at risk for severe illness. The companies have sought US Food and Drug Administration emergency use authorization for the drug, and the FDA said it will convene its Antimicrobial Drugs Advisory Committee …

EU medicines watchdog starts review of Merck COVID pill
3 years, 2 months ago

EU medicines watchdog starts review of Merck COVID pill

Al Jazeera  

The treatment is considered a potential game changer in the global fight against the coronavirus. The European Medicines Agency – the European Union’s top medicines watchdog – has started a review of a potentially ground-breaking antiviral pill to treat COVID-19. The company reported earlier this month that the pill cut hospitalisations and deaths by half among patients with early symptoms …

Merck Covid pill: Asian countries are rushing to buy molnupiravir but poor countries could miss out
3 years, 2 months ago

Merck Covid pill: Asian countries are rushing to buy molnupiravir but poor countries could miss out

CNN  

CNN — During the global scramble to secure vaccines, many countries in Asia-Pacific were slow off the mark. “This is a game changer.” What the Covid pill means for vaccines Vaccines are still the best protection, say experts – after all, they can reduce the risk of a person getting Covid-19 at all. “This drug will be a frontline solution …

Merck seeks FDA emergency use authorization for experimental antiviral Covid-19 treatment molnupiravir
3 years, 2 months ago

Merck seeks FDA emergency use authorization for experimental antiviral Covid-19 treatment molnupiravir

CNN  

CNN — Merck said Monday it is seeking US Food and Drug Administration emergency use authorization for its experimental antiviral Covid-19 treatment, molnupiravir. “At the interim analysis, molnupiravir reduced the risk of hospitalization or death by approximately 50%; 7.3% of patients who received molnupiravir were either hospitalized or died through Day 29 following randomization, compared with 14.1% of placebo-treated patients,” …

Merck seeks US authorisation for pill to treat COVID
3 years, 2 months ago

Merck seeks US authorisation for pill to treat COVID

Al Jazeera  

US pharmaceutical giant submits request for FDA approval for molnupiravir pill to treat mild-to-moderate COVID-19 cases. US pharmaceutical company Merck has requested emergency authorisation for its experimental pill to treat mild-to-moderate cases of COVID-19, in what would add a promising, new tool to the global fight against the virus. Merck submitted the application for molnupiravir, which it said earlier this …

2 Indian Firms Seek Regulator Nod to Cease Trials of anti-Covid Pill Molnupiravir on 'Moderate' Patients
3 years, 2 months ago

2 Indian Firms Seek Regulator Nod to Cease Trials of anti-Covid Pill Molnupiravir on 'Moderate' Patients

News 18  

Two pharmaceutical companies have sought permission from India’s drug regulator to discontinue the phase III trials of American firm Merck & Co’s experimental antiviral drug molnupiravir in moderate Covid-19 patients, a government document shows, though one of the two manufacturers told News18.com that the “results have come out exceedingly well” in mild cases. Aurobindo Pharma and MSN Laboratories have presented …

New coronavirus anti-viral med is “welcome, but not a miracle cure”: Virologist
3 years, 2 months ago

New coronavirus anti-viral med is “welcome, but not a miracle cure”: Virologist

NL Times  

Pharmaceutical company Merck announced last week that its antiviral medicine Molnupiravir could prevent 50 percent of coronavirus-related hospital admissions and deaths in high-risk groups if administered in time. According to virologists, this new treatment is a "welcome addition," but not a "miracle cure," they said to NOS. According to him, especially oral administration is "a welcome addition" to the treatment …

EXPLAINED: A Pill You Can Pop At Home To Beat Covid. Here's Why Merck's Antiviral Drug Is Raising Hopes
3 years, 2 months ago

EXPLAINED: A Pill You Can Pop At Home To Beat Covid. Here's Why Merck's Antiviral Drug Is Raising Hopes

News 18  

The global death toll from Covid-19 is said to now have crossed 5 million even as the pandemic’s end is yet to appear within sight. Merck, which has partnered the US-based Ridgeback Biotherapeutics for the development of the drug, said that Phase-3 trials showed that it “significantly reduced the risk of hospitalisation or death… in at risk, non-hospitalised adult patients …

Explained | Molnupiravir, Merck’s new drug to treat COVID-19
3 years, 2 months ago

Explained | Molnupiravir, Merck’s new drug to treat COVID-19

The Hindu  

Why is there much excitement about molnupiravir, the investigational new drug for COVID-19? Pharmaceutical major Merck and Ridgeback Biotherapeutics announced via a press release on October 1 the early results from Phase-3 trials that its anti-viral drug molnupiravir halved the chances of hospitalisation in COVID-19 patients with mild or moderate disease. Several noted clinicians have said that these are promising …

Merck’s Molnupiravir, Glenmark’s Nasal Spray, Zydus' Antibody Cocktail: 20+ Drugs in Pipeline for Covid
3 years, 2 months ago

Merck’s Molnupiravir, Glenmark’s Nasal Spray, Zydus' Antibody Cocktail: 20+ Drugs in Pipeline for Covid

News 18  

Merck’s Molnupiravir, Zydus’ antibody cocktail and Glenmark’s nasal spray are among more than 20 new drugs in different stages of drug trials or approvals in India to treat Covid-19. “As the world needs Covid-19 vaccines, the world also needs proven and effective Covid-19 therapies,” Lahariya said. List of Drugs in the Pipeline US pharma giant Merck and Ridgeback Biotherapeutics’ oral …

Merck Covid pill: What would an antiviral pill mean for the fight against Covid-19?
3 years, 2 months ago

Merck Covid pill: What would an antiviral pill mean for the fight against Covid-19?

CNN  

CNN — Merck and Ridgeback Biotherapeutics announced on Friday early result that indicate their experimental oral antiviral drug molnupiravir might halve the risk of death or hospitalization from Covid-19. But Merck says it will seek authorization from the US Food and Drug Administration, and if it’s granted, the drug could be the first antiviral treatment available orally to fight Covid-19. …

Merck antiviral pill raises hope of preventing COVID-19 deaths
3 years, 2 months ago

Merck antiviral pill raises hope of preventing COVID-19 deaths

The Hindu  

An antiviral pill developed by U.S. drug maker Merck & Co could half the chances of dying or being hospitalized for those most at risk of contracting severe COVID-19, with experts hailing it as a potential breakthrough in how the virus is treated. Merck and partner Ridgeback Biotherapeutics said they plan to seek U.S. emergency use authorization for the pill …

Covid pill works against all variants including Delta, manufacturer says
3 years, 2 months ago

Covid pill works against all variants including Delta, manufacturer says

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Drugmaker Merck & Co’s experimental …

US to spend $3.2B on treatments for COVID-19, other viruses
3 years, 6 months ago

US to spend $3.2B on treatments for COVID-19, other viruses

Associated Press  

WASHINGTON — The United States is devoting $3.2 billion to speed development of antiviral pills to treat COVID-19 and other dangerous viruses that could turn into pandemics. The new program will invest in “accelerating things that are already in progress” for COVID-19 but also would work to come up with treatments for other viruses, said Dr. Anthony Fauci, the nation’s …

MSN Laboratories to start phase 3 clinical trial of covid-19 drug molnupiravir
3 years, 7 months ago

MSN Laboratories to start phase 3 clinical trial of covid-19 drug molnupiravir

Live Mint  

NEW DELHI: MSN Laboratories Pvt Ltd on Tuesday announced that it is starting phase 3 clinical trial of molnupiravir capsules for treatment of mild-to-moderate covid-19 in India. It will soon start clinical trials on more than 2,400 patients suffering from mild to moderate covid-19 at more than 40 sites across India. MSN’s phase 3 trial is the third firm to …

UK Scientists Trial Instant Immunity Antibody Drug Treatment for Coronavirus
3 years, 11 months ago

UK Scientists Trial Instant Immunity Antibody Drug Treatment for Coronavirus

News 18  

Scientists in the UK have begun trials of innovative antibody drug treatments that they hope could provide instant protection against COVID-19. The University College London Hospitals NHS Trust said that the researchers in the Storm Chase study believe a Long Acting AntiBody known as AZD7442, developed by AstraZeneca, may offer immediate and long-term protection to people who have been recently …

Oral antiviral drug Molnupiravir can block spread of SARS-CoV-2 virus in ferrets, study shows
4 years ago

Oral antiviral drug Molnupiravir can block spread of SARS-CoV-2 virus in ferrets, study shows

Firstpost  

Molnupiravir is now in the advanced phase, multi-centre, clinical II/III trials in human beings after successful completion of phase I safety trials. For the first time since the Covid-19 pandemic began in December last year, an antiviral oral drug has been developed that can stop the spread of the transmission of SARS-CoV-2 within 24 hours. Dr Richard Plemper, Distinguished University …

New antiviral oral drug molnupiravir completely suppresses coronavirus transmission within 24 hours in ferrets, claims study
4 years ago

New antiviral oral drug molnupiravir completely suppresses coronavirus transmission within 24 hours in ferrets, claims study

Firstpost  

Researchers claim that MK-4482/EIDD-2801 or molnupiravir is the first orally available drug to quickly block SARS-CoV-2 and has the potential of being ground-breaking From the very beginning of the COVID-19 pandemic, the focus of the global scientific and healthcare research community has been to either discover new treatment options or vaccines that can kill SARS-CoV-2 or repurpose old drugs to …

Coronavirus Australia live news: Victoria announces free kinder for 2021, SA to decide on border this Friday
4 years, 1 month ago

Coronavirus Australia live news: Victoria announces free kinder for 2021, SA to decide on border this Friday

ABC  

This antibody drug is not the same one that was given to US President Donald Trump when he caught coronavirus, but it is a very similar treatment. The Food and Drug Administration granted emergency use authorisation to Eli Lilly & Co's bamlanivimab based on trial data showing that a one-time infusion of the treatment reduced the need for hospitalisation or …

Coronavirus | Repurposed drugs did not cut down mortality, says WHO
4 years, 2 months ago

Coronavirus | Repurposed drugs did not cut down mortality, says WHO

The Hindu  

Interim results from the Solidarity Therapeutics Trial, coordinated by the World Health Organization, have indicated that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalised patients as per information released by the World Health Organisation. Speaking exclusively to The Hindu, about the outcome Prof. K …

Antiviral Drug Used to Treat Cats May Also Work Against Covid-19, Say Scientists
4 years, 3 months ago

Antiviral Drug Used to Treat Cats May Also Work Against Covid-19, Say Scientists

News 18  

Even as the world grapples with the deadly coronavirus pandemic, we still don’t have a cure for the disease yet. A drug used to cure a deadly viral disease in cats may be effective as a treatment for humans against the novel coronavirus, according to a study that may lead to the development of new therapeutics to treat COVID-19. “This …

COVID-19: Antiviral drug used to treat cats may be effective in treating humans against coronavirus
4 years, 3 months ago

COVID-19: Antiviral drug used to treat cats may be effective in treating humans against coronavirus

Hindustan Times  

A drug used to cure a deadly viral disease in cats may be effective as a treatment for humans against the novel coronavirus, according to a study that may lead to the development of new therapeutics to treat COVID-19. “This drug is very likely to work in humans, so we’re encouraged that it will be an effective antiviral treatment for …

Discover Related